rEduction of oXygen After Cardiac arresT: a Pilot Study
NCT ID: NCT02499042
Last Updated: 2017-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE2
59 participants
INTERVENTIONAL
2015-07-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ventilation Monitoring in OHCA
NCT04988906
Automatic Ventilation in Prehospital Resuscitation on OHCA
NCT06067204
Blood Pressure and OXygenation Targets After OHCA
NCT03141099
Carbon Dioxide, Oxygen and Mean Arterial Pressure After Cardiac Arrest and Resuscitation
NCT02698917
Cardiac Catheterization in Cardiac Arrest
NCT02587494
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: There is no difference in the proportion of OHCA patients who arrive at the emergency department with oxygen saturation greater than or equal to 90% whether they received an inspired oxygen fraction of 100% achieved by a flow rate of 10 litres per minute compared to a titrated oxygen fraction achieved by a flow rate of 2 litres per minute.
This is a Phase 2, multi-centre, prospective, randomised study to be conducted in Melbourne and Adelaide.
During cardiac arrest, the patient will receive the current standard of care with oxygen delivery (≥10L/min) by ETT/ SGA connected to bag/valve/ oxygen reservoir.
If ROSC is achieved, all the standard post resuscitation treatments will be given as per current ambulance Clinical Practice Guidelines, except for the amount of oxygen delivered.
The initial ventilation post ROSC for two minutes will be 600mL x 10L/ minute with oxygen flow rate ≥10L/min until a satisfactory pulse oximeter trace and reading is achieved.
After the eligibility criteria are met, the patients will be randomised by the opening of an opaque envelope containing a computer generated allocation to either continued oxygen \>10L/min or decreased ("titrated") oxygen 2L/min with a target oxygen saturation of 90-94%.
Patients allocated to oxygen \>10L minute ("standard care") will continue on this therapy to hospital.
In the 2L/min oxygen group, the oxygen flow will be changed immediately back to \>10L/min if:
* The oxygen saturation falls to \<90% at any time, or
* Recurrent cardiac arrest occurs, or
* The pulse oximeter trace fails Following any of these events, this high-flow oxygen will continue to hospital. If a patient is extubated or has a SGA removed post randomisation because of improving conscious state, then standard care will be used (i.e. face mask with oxygen ≥10L/min).
For patients with ROSC in whom intubation is planned, ventilation with high-flow oxygen will continue during the intubation process and randomisation will be delayed until 2 minutes after the ETT is confirmed as correctly placed using ETCO2 and the pulse oximeter trace reads ≥95%.
At ED handover, the patient will receive oxygen therapy as determined by the treating emergency medicine physician.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oxygen reduction
post-ROSC oxygen reduced to 2L per minute then delivered to maintain oxygen saturation 90-94% to hospital
Oxygen
oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
Standard Care
post-ROSC oxygen maintained ≥10L per minute to hospital
Oxygen
oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Oxygen
oxygen delivery by ETT/ SGA connected to bag/valve/oxygen reservoir
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Out-of-hospital cardiac arrest of presumed cardiac cause
* Initial cardiac rhythm ventricular fibrillation/ ventricular tachycardia ("shockable")
* Unconscious (Glasgow Coma Scale \<9)
* In cardiac arrest on ambulance arrival
* Sustained return of spontaneous circulation (\>2 minutes)
* Pulse oximeter trace with oxygen saturation measured at ≥95% on bag/ reservoir with oxygen set at ≥10L/min
* Patient is spontaneous breathing or ventilated using bag/valve/oxygen reservoir via endotracheal tube or SGA (i.e. laryngeal mask airway)
Exclusion Criteria
* Dependant on others for activities of daily living (i.e. facilitated care or nursing home residents)
* "Not for Resuscitation" order
* EMS witnessed arrests
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ambulance Victoria
OTHER_GOV
SA Ambulance Service
UNKNOWN
Curtin University
OTHER
Flinders University
OTHER
Monash University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Stephen Bernard
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stephen Bernard, MD
Role: PRINCIPAL_INVESTIGATOR
Monash University / Alfred Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SA Ambulance Service
Adelaide, South Australia, Australia
Ambulance Victoria
Melbourne, Victoria, Australia
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bray JE, Hein C, Smith K, Stephenson M, Grantham H, Finn J, Stub D, Cameron P, Bernard S; EXACT Investigators. Oxygen titration after resuscitation from out-of-hospital cardiac arrest: A multi-centre, randomised controlled pilot study (the EXACT pilot trial). Resuscitation. 2018 Jul;128:211-215. doi: 10.1016/j.resuscitation.2018.04.019. Epub 2018 Apr 21.
Related Links
Access external resources that provide additional context or updates about the study.
The Australian Resuscitation Outcomes Consortium (Aus-ROC)
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CF14/2953-2014001634
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.